Mark Cuban-backed D.C. startup developing vertigo treatment raises $20M in Series A round


The company's wearable device has already been designated a breakthrough product by the FDA.

Previous Durham clinical firm reaches 5 more states, key groups with latest acquisition
Next NIH pumping millions into ovarian cancer research